back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-09 16:58 Tx date 2026-09-04 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,599
+55,000 vol $2.32 each |
340,000 | |
| Filed 2026-09-09 16:41 Tx date 2026-09-04 |
$NGEN
NervGen Pharma Corp. |
Thompson, John Craig
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,599
+55,000 vol $2.32 each |
440,000 | |
| Filed 2026-09-09 16:39 Tx date 2026-09-04 |
$NGEN
NervGen Pharma Corp. |
Kaye, Randall
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,599
+55,000 vol $2.32 each |
540,000 | |
| Filed 2026-09-09 16:37 Tx date 2026-09-04 |
$NGEN
NervGen Pharma Corp. |
Ruffolo, John
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,599
+55,000 vol $2.32 each |
305,000 | |
| Filed 2026-09-09 16:33 Tx date 2026-09-04 |
$NGEN
NervGen Pharma Corp. |
Klompas, Neil
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,599
+55,000 vol $2.32 each |
265,000 | |
| Filed 2026-09-09 16:25 Tx date 2026-09-04 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,599
+55,000 vol $2.32 each |
280,000 | |
| Filed 2026-09-09 16:24 Tx date 2026-09-04 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$36,073
+17,178 vol $2.10 each |
1,196,960 | |
| Filed 2026-09-09 16:23 Tx date 2026-09-04 |
$NGEN
NervGen Pharma Corp. |
Punnett, Harold
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-105,000
-50,000 vol $2.10 each |
225,000 | |
| Filed 2026-09-08 13:48 Tx date 2026-09-04 |
$NGEN
NervGen Pharma Corp. |
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+55,000 vol |
280,000 | |
| Filed 2026-09-08 13:45 Tx date 2026-09-04 |
$NGEN
NervGen Pharma Corp. |
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$105,000
+50,000 vol $2.10 each |
615,000 | |
| Filed 2026-09-08 13:44 Tx date 2026-09-04 |
$NGEN
NervGen Pharma Corp. |
Bayley, Brian Eric
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-105,000
-50,000 vol $2.10 each |
225,000 | |
| Filed 2026-08-31 17:13 Tx date 2026-08-28 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$37,016
+17,627 vol $2.10 each |
17,627 | |
| Filed 2026-08-31 17:12 Tx date 2021-09-09 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-08-31 17:09 Tx date 2026-08-28 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-105,000
-50,000 vol $2.10 each |
285,000 | |
| Filed 2026-08-31 17:06 Tx date 2026-08-24 |
$NGEN
NervGen Pharma Corp. |
Kaye, Randall
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$18,845
+8,974 vol $2.10 each |
168,974 | |
| Filed 2026-08-31 17:04 Tx date 2026-08-24 |
$NGEN
NervGen Pharma Corp. |
Kaye, Randall
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-105,000
-50,000 vol $2.10 each |
485,000 | |
| Filed 2026-08-05 21:05 Tx date 2026-07-28 |
$NGEN
NervGen Pharma Corp. |
Ruffolo, John
4 - Director of Issuer
Holder: Caymus Ruffolo (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$328.00
+200 vol $1.64 each |
200 | |
| Filed 2026-08-05 21:04 Tx date 2023-10-16 |
$NGEN
NervGen Pharma Corp. |
Ruffolo, John
4 - Director of Issuer
Holder: Caymus Ruffolo (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-07-08 16:27 Tx date 2026-06-30 |
$NGEN
NervGen Pharma Corp. |
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$224,635
+61,713 vol $3.64 each |
119,497 | |
| Filed 2026-07-08 16:25 Tx date 2026-06-30 |
$NGEN
NervGen Pharma Corp. |
Rogers, Adam
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$137,533
+37,784 vol $3.64 each |
57,784 |